Is it known whether the active ingredients in Anoro Ellipta pass into human breast milk?

It is unknown whether Anoro Ellipta’s umeclidinium or vilanterol pass into human breast milk; infant risk cannot be excluded, so whether to discontinue breast-feeding or treatment must be decided by weighing breast-feeding benefits for the child against treatment benefits for the woman.